PLoS Clinical Trials (PCT)
Journal Descriptions
PLoS Clinical Trials was an open-access peer-reviewed medical journal launched by the Public Library of Science (PLOS) in 2006. The journal focused specifically on publishing randomized clinical trials and evidence-based medical research from all areas of medicine and public health. Its primary objective was to improve transparency and accessibility in clinical trial reporting by making research findings freely available to healthcare professionals, researchers, and the public worldwide. The journal accepted studies regardless of perceived novelty, provided the research was scientifically and ethically sound. This publishing approach supported the reduction of publication bias, especially for negative or inconclusive clinical trial results that were often underreported in traditional medical journals. Topics covered included therapeutic interventions, drug efficacy, treatment safety, epidemiology, and healthcare outcomes research. PLoS Clinical Trials was one of the earliest experiments in large-scale open-access clinical trial publishing and contributed significantly to discussions on scientific transparency and reproducibility in medicine. Due to strategic restructuring within PLOS, the journal ceased publication in 2007, and its content was integrated into PLOS ONE, which expanded the multidisciplinary open-access publishing model internationally.
PLoS Clinical Trials (PCT) is :-
-
International, Peer-Reviewed, Open Access, Refereed, Clinical trials, Evidence-based medicine, Public health, General medicine, Pharmacology, Medical research methodology, therapeutic interventions, drug efficacy, treatment safety, epidemiology, healthcare outcomes research , Online , Continuously Journal
- UGC Approved, ISSN Approved: P-ISSN E-ISSN: 1555-5887, Established: 2006,
- Does Not Provide Crossref DOI
-
Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE